Colgate-Palmolive Company$93.37KVUE · NYSE
| FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Total Revenue | $15.12B | $15.46B | $15.44B | $14.95B | $15.05B |
| Cost of Revenue | $6.33B | $6.50B | $6.80B | $6.67B | $6.63B |
| Gross Profit | $8.79B | $8.96B | $8.64B | $8.29B | $8.42B |
| Research & Development | $382.00M | $408.00M | $399.00M | $375.00M | $355.00M |
| Selling, General & Administrative | $6.09B | $6.33B | $6.14B | $5.63B | $5.48B |
| Operating Income | $2.41B | $1.84B | $2.51B | $2.67B | $2.92B |
| Interest Expense | $430.00M | $431.00M | $250.00M | $0.00 | $0.00 |
| Other Income / (Expense) | -$36.00M | -$48.00M | -$72.00M | -$38.00M | $5.00M |
| Income Before Taxes | $2.00B | $1.42B | $2.19B | $2.64B | $2.92B |
| Provision for Income Taxes | $529.00M | $385.00M | $526.00M | $573.00M | $847.00M |
| Net Income | $1.47B | $1.03B | $1.66B | $2.06B | $2.08B |
| Basic EPS | $0.77 | $0.54 | $0.90 | $1.20 | $1.21 |
| Diluted EPS | $0.76 | $0.54 | $0.90 | $1.20 | $1.21 |
| Basic Shares Outstanding | 1.92B | 1.92B | 1.85B | 1.72B | 1.72B |
| Diluted Shares Outstanding | 1.92B | 1.92B | 1.85B | 1.72B | 1.72B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $1.16 | $1.02 | $1.26 | 5 | ↑0 ↓0 |
| Dec 2027 | $1.23 | $1.10 | $1.35 | 5 | ↑0 ↓0 |
| Dec 2028 | $1.32 | $1.28 | $1.36 | 2 | ↑0 ↓0 |
| Dec 2029 | $1.39 | $1.36 | $1.41 | 2 | ↑0 ↓0 |
